All News Catalent, Inc.

Equities

Market Closed - Nyse Other stock markets 04:00:02 2024-06-07 pm EDT			5-day change	1st Jan Change
56.39 ^USD	+0.32%		+4.83%	+25.51%

May. 29	Catalent Shareholders Approve Deal With Novo Holdings	MT
May. 29	Catalent stockholders approve deal with Novo Holdings	RE

Ardena appoints Jeremie Trochu as Chief Executive Officer	Jun. 07	AQ
Catalent Shareholders Approve Deal With Novo Holdings	May. 29	MT
Catalent stockholders approve deal with Novo Holdings	May. 29	RE
Catalent Stockholders Approve Transaction with Novo Holdings	May. 29	BU
Argus Downgrades Catalent to Sell From Buy	May. 16	MT
Novo Nordisk Selling $5 Billion in Bonds to Back Catalent Deal	May. 14	MT
Novo Nordisk Plans First Bond Sale in Two Years	May. 14	MT
Novo Nordisk Plans First Bond Sale in 2 Years	May. 13	MT
MOVES -Lazard hires veteran healthcare dealmaker Colocci as vice chairman	May. 09	RE
Catalent: Fiscal Q3 Earnings Snapshot	May. 08	AQ
Earnings Flash (CTLT) CATALENT Posts Q3 Revenue $1.07B	May. 08	MT
Catalent, Inc. Reports Third Quarter Fiscal 2024 Results	May. 08	BU
Catalent, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024	May. 08	CI
Siren Biotechnology and Catalent Enter Partnership for Manufacturing of AAV Gene Therapies for Cancer	May. 08	CI
Top Midday Stories: Apple's Dividend, Buybacks Announcements; Amgen Obesity Drug Trial Results; Exxon Completes Pioneer Acquisition	May. 03	MT
Catalent, Novo Nordisk Antitrust Review Extended by FTC	May. 03	MT
FTC Seeks More Info On $16.5 Billion Novo/Catalent Deal	May. 03	DJ
US FTC seeks more information on Novo Nordisk parent-Catalent deal	May. 03	RE
FTC seeks more information on Novo Holdings-Catalent deal	May. 03	RE
Obesity drugmaker Novo Nordisk raises outlook, Q1 profit beats forecast	May. 02	RE

No results for this search